Crinetics Pharmaceuticals Competitors and Similar CompaniesClear all

Immatics's competitors and similar companies include Pharming Group and Alexion Pharmaceuticals.

	Immatics Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer.	Pharming Group Pharming Group is a biopharmaceutical company developing protein replacement therapies and precision medicines for the treatment of rare diseases.	Alexion Pharmaceuticals Alexion (also known as Alexion, AstraZeneca Rare Disease) is a biopharmaceutical company engaged in therapies for rare diseases.
Founding Date	Founding Date N/A	Founding Date 1988	Founding Date 1992
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech pharma therapy	Tags Healthcare biotech pharma therapy	Tags Healthcare biotech pharma therapy
Locations	Locations Tübingen, DE HQ Frankfurt Am Main, DE München, DE Houston, US	Locations Leiden, NL HQ Leiden, NL	Locations Boston, US HQ Frenchs Forest, AU Wien, AT Elsene, BE São Paulo, BR Vaughan, CA Shanghai, CN see more
Employees	Employees 29723% increase	Employees 404	Employees 10,6006% increase
Valuation ($)	Valuation ($) 1.1 b	Valuation ($) 590.3 m	Valuation ($) 40.3 b
Financial
Revenue (est.)	Revenue (est.) €48.3m (FY, 2025)	Revenue (est.) $376.1m (FY, 2025)	Revenue (est.) $6.1b (FY, 2020)
Cost of goods	Cost of goods N/A	Cost of goods $41.6m (FY, 2025)	Cost of goods $553.5m (FY, 2020)
Gross profit	Gross profit €53m (FY, 2025)	Gross profit $341m (FY, 2025)	Gross profit $5.5b (FY, 2020)
Net income	Net income (€196.4m) (FY, 2025)	Net income $2.5m (FY, 2025)	Net income $603.4m (FY, 2020)